AUB & Menstrual Disorders: 25 Board-Style MCQs with Full Expert Rationales & Distractor Analysis

DOCUMENT DESCRIPTION Overview This is Module 3 of a three-module comprehensive academic study packet on Abnormal Uterine Bleeding and Menstrual Disorders in Reproductive-Age Women — the Board Exam Preparation Bundle. It is an original educational work authored by Brian Kabinga, designed specifically for medical students, nursing students, nurse practitioner students, and physician assistant students preparing for high-stakes standardized clinical examinations. The module spans 27 professionally formatted pages and delivers 25 clinical vignette MCQs written to the exact format and cognitive complexity of USMLE Step 2 CK, ANCC Family and Adult Health NP certification, AANP certification, and PANCE examinations — followed by a complete expert answer and distractor analysis section for every question, a scored answer key with performance interpretation guide, and two high-yield summary reference tables for pre-examination rapid review. What makes this module distinctively valuable is the distractor analysis — a feature rarely found in student study resources. For every one of the 25 questions, not only is the correct answer explained in full clinical detail, but every single incorrect answer option receives its own dedicated explanation identifying precisely why it is wrong, which pharmacological or physiological principle it violates, and which cognitive trap the examiner designed it to exploit. This approach builds the clinical reasoning precision needed to avoid being misled by attractive but incorrect options under real examination pressure — a skill that answer keys alone can never develop. SECTION A — Examination Instructions and Topic Map The module opens with a complete 12-domain topic coverage map organizing all 25 questions across their clinical subject areas, allowing students to identify weak areas before attempting the examination and to target specific topics for focused review after scoring. The domains covered include AUB structural versus non-structural classification, postmenopausal and high-risk bleeding evaluation, PCOS diagnosis and pathophysiology, fibroid management, adenomyosis and dysmenorrhea, endometrial hyperplasia management, pharmacotherapy, laboratory and diagnostic testing, endometrial ablation candidate selection, adolescent AUB, and comprehensive stepwise management. The section closes with a 10-point High-Yield Exam Pearls callout specifically designed for review in the 24 to 48 hours before an examination, covering the ten most critical clinical reasoning principles across the entire AUB domain. These pearls include the cycle regularity rule, the absolute postmenopausal biopsy mandate, the minimum two-of-three PCOS criterion requirement, the fertility goal contraindications for ablation and hysterectomy, the LNG-IUD cavity distortion contraindication, the GnRH agonist add-back bone protection requirement, the non-hormonal nature of tranexamic acid, the von Willebrand disease screening imperative in adolescents with menarche-onset HMB, the concurrent cancer risk percentage for atypical hyperplasia, and the hyperinsulinemia versus hyperglycemia mechanism of acanthosis nigricans. SECTION B — 25 Clinical Vignette Examination Questions Twenty-five original clinical vignette questions are presented in standard board examination format — each with a realistic patient scenario, relevant clinical context, and five answer options requiring selection of the single best answer. The questions progress through all 12 clinical domains and are calibrated to the difficulty level of USMLE Step 2 CK and advanced nursing certification examinations. The complete list of questions and their clinical focus is as follows. Question 1 tests AUB structural classification — a 38-year-old with heavy regular bleeding and an intracavitary mass, requiring correct application of the PALM-COEIN framework and recognition of cycle regularity as the key differentiating clue between structural and anovulatory causes. Question 2 tests postmenopausal bleeding evaluation — a 62-year-old obese diabetic nulliparous woman with two bleeding episodes 14 years after menopause, requiring selection of endometrial biopsy as the mandatory first step regardless of clinical alternative diagnoses. Question 3 tests the three-criterion PCOS diagnostic framework — a 24-year-old with oligomenorrhea and hirsutism but normal serum testosterone, requiring recognition that clinical hyperandrogenism is valid even without laboratory confirmation. Question 4 tests non-hormonal HMB management in a fertility-planning patient — a 29-year-old planning pregnancy within six months requiring a treatment that reduces menstrual blood loss without affecting ovulation or implantation. Question 5 tests premenopausal endometrial biopsy indications — a 43-year-old obese woman with PCOS and four months of irregular heavy bleeding, where hormonal treatment empirically without prior biopsy is the clinical error being tested. Question 6 tests adenomyosis diagnosis — a 41-year-old multiparous woman with progressive dysmenorrhea, ibuprofen failure, a globular boggy uterus, and heterogeneous myometrium on imaging, requiring distinction from fibroids, endometriosis, and endometritis. Question 7 tests pathognomonic physical signs of chronic iron deficiency — a 35-year-old with hemoglobin 7.8 and ferritin 3, requiring identification of koilonychia as the most diagnostically specific finding versus non-specific signs common to all anemia etiologies. Question 8 tests fibroid management when fertility is desired — a 32-year-old with a FIGO Type 0 submucosal fibroid and recurrent pregnancy loss, requiring selection of hysteroscopic myomectomy as the only fertility-preserving option that directly addresses both the bleeding and the pregnancy loss. Question 9 tests atypical hyperplasia management — a 46-year-old with endometrial intraepithelial neoplasia on biopsy who has completed her family, requiring mandatory oncology referral based on the 25 to 33 percent concurrent cancer risk. Question 10 tests acanthosis nigricans pathophysiology — a 25-year-old PCOS patient with acanthosis nigricans, HOMA-IR of 5.8, and completely normal fasting glucose, requiring identification of hyperinsulinemia rather than hyperglycemia as the causal mechanism. Question 11 tests the primacy of fertility goal documentation — a 36-year-old with multiple fibroids where the single most critical history item must be identified before any treatment recommendation is made. Question 12 tests von Willebrand disease screening in adolescence — a 15-year-old with catastrophic menstrual bleeding at her second period, epistaxis requiring nasal packing, prolonged dental bleeding, and a maternal bleeding history, requiring the specific vWD laboratory panel. Question 13 tests cycle pattern as a diagnostic differentiator — two patients with contrasting regular versus irregular cycle patterns requiring correct assignment of structural versus anovulatory mechanism to each. Question 14 tests LNG-IUD contraindication from cavity distortion — a 40-year-old with a 4.5 cm submucosal fibroid distorting the cavity, requiring understanding that the contraindication is specifically cavity distortion rather than fibroid presence alone. Question 15 tests GnRH agonist add-back therapy — a 34-year-old on a GnRH agonist for 4 months with menopausal symptoms and a planned 12-month course without modification, requiring identification of progressive bone mineral density loss as the primary clinical concern. Question 16 tests primary versus secondary dysmenorrhea — a 19-year-old with stable dysmenorrhea since menarche, complete NSAID response, and normal examination and imaging, requiring recognition that complete NSAID response argues strongly against endometriosis and adenomyosis. Question 17 tests metabolic syndrome criteria counting and first-line management — a 27-year-old PCOS patient meeting all five metabolic syndrome criteria, requiring correct identification of intensive lifestyle modification as the most important first-line intervention. Question 18 tests endometrial ablation candidate selection — five patients with different clinical profiles, requiring identification of the one patient who meets all five criteria for appropriate candidacy while understanding the specific contraindication disqualifying each other patient. Question 19 tests adolescent AUB and HPO axis maturation — a 16-year-old with irregular cycles within two years of menarche and no pathological features, requiring recognition of physiological HPO axis immaturity as the most likely explanation. Question 20 tests tranexamic acid mechanism and fertility compatibility — a 33-year-old with ovulatory HMB asking specifically how the medication works and whether it affects fertility, requiring complete mechanistic explanation of the antifibrinolytic pathway and the absence of any hormonal activity. Question 21 tests ovulation confirmation laboratory timing — a 26-year-old with cycles every 35 to 50 days needing biochemical anovulation confirmation, requiring correct identification of midluteal progesterone timed relative to the expected next period rather than from cycle day one. Question 22 tests hysteroscopy as the appropriate next step for an intracavitary lesion — a 45-year-old with a 1.2 cm echogenic lesion and HMB, requiring selection of the investigation that simultaneously provides definitive diagnosis and definitive treatment in a single session. Question 23 tests chronic anovulation endometrial protection — a 30-year-old PCOS patient with five months of amenorrhea declining oral contraceptives, requiring identification of progestin-induced withdrawal bleeding every three months as the minimum acceptable endometrial protection threshold. Question 24 tests comprehensive multimodal AUB evaluation — a complex 37-year-old with thickened endometrium, irregular cycles, overweight BMI, and impaired fasting glucose, requiring the complete five-investigation panel and rejection of any single-modality approach. Question 25 tests comprehensive stepwise fibroid management — a 34-year-old with completed family, hemoglobin 9.2, and both submucosal and intramural fibroids seeking the most effective long-term solution, requiring the complete three-step integrated management plan and specific understanding of why each alternative answer is inadequate or contraindicated. SECTION C — Expert Answer Rationales for All 25 Questions This is the educationally densest and most distinctive section of the module. For every question the layout follows a consistent structure — a correct answer confirmation box in green, a full clinical rationale paragraph explaining the mechanism behind the correct answer, followed by individually boxed distractor explanations for every incorrect option in red. The distractor explanation philosophy is deliberately adversarial — each wrong answer entry does not simply state that the option is incorrect, but specifically identifies which cognitive trap or knowledge gap the examiner designed it to exploit. Students who read every distractor explanation across all 25 questions will have engaged with more than 100 individual clinical reasoning errors — building examination immunity against the most commonly tested AUB clinical decision mistakes. The combined effect of reading all 25 correct rationales alongside all 100 distractor explanations produces a comprehensive, mechanism-level understanding of every major AUB clinical decision point targeted on board examinations — an educational depth that no standard answer key can replicate. SECTION D — High-Yield Summary Reference Tables Two comprehensive tables close the module, formatted for rapid pre-examination review. The AUB Treatment Eligibility by Fertility Status Table covers ten treatment modalities with color-coded eligibility indicators for fertility-desiring patients versus patients with completed fertility, and a key notes column summarizing the most important clinical consideration for each treatment. The ten modalities covered are tranexamic acid, NSAIDs, combined oral contraceptive pill, levonorgestrel IUD, GnRH agonist therapy, hysteroscopic myomectomy, uterine artery embolization, endometrial ablation, and hysterectomy. This table provides a complete at-a-glance treatment selection framework reviewable in under two minutes. The Key Diagnostic Criteria Quick Reference Table covers seven clinical conditions — PCOS, heavy menstrual bleeding, biochemical anovulation confirmation, iron deficiency anemia, metabolic syndrome, endometrial biopsy indications, and atypical hyperplasia — with specific diagnostic thresholds, criterion counts, and the single most important clinical pearl for each condition. This table consolidates the most frequently examined diagnostic thresholds across the entire AUB clinical domain into one rapid-reference resource. Who This Document Is For This board exam bundle is specifically designed for medical students preparing for USMLE Step 2 CK shelf examinations and clerkship OSCE assessments, nursing and nurse practitioner students using iHuman simulation platforms and preparing for ANCC or AANP board certification, physician assistant students preparing for PANCE and PANRE gynecology content, residents rotating through obstetrics and gynecology or family medicine who need to consolidate core AUB clinical decision-making, and students who have previously struggled with the PALM-COEIN classification framework, the PCOS three-criterion diagnostic application, the fertility-goal-based treatment selection algorithm, or the endometrial cancer risk assessment framework that governs postmenopausal and high-risk premenopausal AUB evaluation. Document Design The module uses a professional academic color palette — Rose, Navy, Teal, Gold, Red, and Green — with category bars on every question header, green confirmation boxes for correct answers, red distractor boxes for wrong answer explanations, and color-coded summary tables throughout. Every page carries the module title, page number, author attribution crediting Brian Kabinga as the original author, and an originality footer. The PDF was generated at professional typographic quality on US Letter sizing, designed for both digital examination simulation and high-quality printing.